Clinical Trial Update: A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC

View source ↗

Summary

A prospective study at Shanghai Chest Hospital is evaluating how consistently next-generation sequencing panels perform using malignant pleural effusion samples…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion
• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Malignant Hydrothorax, NSCLC | Status: UNKNOWN